Sarcopenia and Non-Ischemic Cardiomyopathy After Liver Transplantation
1Medicine, Division of Gastroenterolgy and Hepatology, Thomas Jefferson University, Philadelphia, PA
2Radiology, Thomas Jefferson University, Philadelphia, PA
3Surgery, Division of Transplantation, Thomas Jefferson University, Philadelphia, PA.
Meeting: 2015 American Transplant Congress
Abstract number: C134
Keywords: Echocardiography, Heart failure, Outcome, Weight
Session Information
Session Name: Poster Session C: Liver Retransplantation and Other Complications
Session Type: Poster Session
Date: Monday, May 4, 2015
Session Time: 5:30pm-6:30pm
Presentation Time: 5:30pm-6:30pm
Location: Exhibit Hall E
Introduction: We describe 3 cases of non-ischemic cardiomyopathy (NICM) following liver transplantation (LT) in patients with pre-transplant sarcopenia.
Reports: All 3 patients were transplanted at a single center. The patients were noted to have pre-transplant sarcopenia, as determined by their mean total psoas area (TPA) at L4 on CT or MRI pre-transplant imaging.
Patient 1 is a 62-year-old male (MELD 13, body mass index (BMI) 19.8) diagnosed with hepatocellular carcinoma (HCC) in the setting of hepatitis C (HCV) cirrhosis who had a normal preoperative transthoracic echocardiogram (TTE) with a left ventricular function ejection fraction (LVEF) of 60% and a normal dobutamine stress echocardiogram (DSE). Four months after LT, repeat TTE was performed which showed decreased EF of 31% with mild to moderate global LV dysfunction. Diagnostic left heart catheterization showed non-significant 60% stenosis of the 2nd diagonal coronary artery. Patient expired 11 months post LT.
Patient 2 is a 61-year-old male (MELD 23, BMI 20.5) diagnosed with HCC in the setting of HCV cirrhosis who had a pre LT TTE with an LVEF of 60% and normal DSE. Repeat TTE performed two months after LT demonstrated EF of 10% with severe global LV dysfunction. Normal LV function has not returned at 5-months post LT.
Patient 3 is a 60-year-old male (MELD 29, BMI 18.9) diagnosed with HCV cirrhosis who had pre LT TTE with a normal LVEF of 75% and normal DSE. TTE performed three months after LT showed EF of 35% with moderate global LV dysfunction. Diagnostic left heart catheterization showed minor luminal irregularities. Patient expired 7 months post LT.
Discussion: Few previous retrospective studies have evaluated clinical predictors of new-onset heart failure post-LT. Although NICM is thought to be a rare complication, critically ill, high MELD patients, particularly those with severe malnutrition, may be at highest risk. Sarcopenia, as seen in all 3 of our patients, is an indicator of nutritional status and should be studied further as a possible predictor for the development of NICM post LT. Pre-operative optimization of nutritional status, in addition to, close post-LT TTE monitoring is advised in this population at risk for adverse cardiovascular outcomes post-LT.
To cite this abstract in AMA style:
Mathew A, Pan J, Guglielmo F, Shah A, Doria C, Sass D, Marzio DHalegoua-De. Sarcopenia and Non-Ischemic Cardiomyopathy After Liver Transplantation [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/sarcopenia-and-non-ischemic-cardiomyopathy-after-liver-transplantation/. Accessed November 21, 2024.« Back to 2015 American Transplant Congress